Cvijetić, I.N.; Herlah, B.; Marinković, A.; Perdih, A.; Bjelogrlić, S.K.
Phenotypic Discovery of Thiocarbohydrazone with Anticancer Properties and Catalytic Inhibition of Human DNA Topoisomerase IIα. Pharmaceuticals 2023, 16, 341.
https://doi.org/10.3390/ph16030341
AMA Style
Cvijetić IN, Herlah B, Marinković A, Perdih A, Bjelogrlić SK.
Phenotypic Discovery of Thiocarbohydrazone with Anticancer Properties and Catalytic Inhibition of Human DNA Topoisomerase IIα. Pharmaceuticals. 2023; 16(3):341.
https://doi.org/10.3390/ph16030341
Chicago/Turabian Style
Cvijetić, Ilija N., Barbara Herlah, Aleksandar Marinković, Andrej Perdih, and Snežana K. Bjelogrlić.
2023. "Phenotypic Discovery of Thiocarbohydrazone with Anticancer Properties and Catalytic Inhibition of Human DNA Topoisomerase IIα" Pharmaceuticals 16, no. 3: 341.
https://doi.org/10.3390/ph16030341
APA Style
Cvijetić, I. N., Herlah, B., Marinković, A., Perdih, A., & Bjelogrlić, S. K.
(2023). Phenotypic Discovery of Thiocarbohydrazone with Anticancer Properties and Catalytic Inhibition of Human DNA Topoisomerase IIα. Pharmaceuticals, 16(3), 341.
https://doi.org/10.3390/ph16030341